American society of hematology, 51st annual meeting and exposition.
To further its mission of promoting the understanding, diagnosis, treatment, and prevention of blood disorders, the American Society of Hematology (ASH) hosted more than 21,000 attendees, including health care professionals, clinicians, guests, and about 3,600 exhibitors, in New Orleans from December 5 to 8, 2009. There were 978 oral presentations and about 3,100 poster presentations. In addition to trials of medications for chronic myelogenous leukemia, this article includes a review of selected evaluations of agents for less common blood disorders.
Alexander
Walter
W